These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1743319)

  • 1. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea.
    Shangold MM; Tomai TP; Cook JD; Jacobs SL; Zinaman MJ; Chin SY; Simon JA
    Fertil Steril; 1991 Dec; 56(6):1040-7. PubMed ID: 1743319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
    Battino S; Ben-Ami M; Geslevich Y; Weiner E; Shalev E
    Gynecol Obstet Invest; 1996; 42(2):113-6. PubMed ID: 8878716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].
    Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amenorrhea during menopausal hormone replacement therapy with a percutaneous estradiol and oral micronized progesterone combination].
    Faguer B; Gillet JY; André G; Philippe E
    Contracept Fertil Sex; 1993 Nov; 21(11):849-52. PubMed ID: 8281238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
    Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
    Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of amenorrhea during hormone replacement therapy: optimal micronized progesterone dose. A multicenter study.
    Gillet JY; Andre G; Faguer B; Erny R; Buvat-Herbaut M; Domin MA; Kuhn JM; Hedon B; Drapier-Faure E; Barrat J
    Maturitas; 1994 Aug; 19(2):103-15. PubMed ID: 7968643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study.
    Panay N; Pritsch M; Alt J
    Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
    Sturdee DW; Archer DF; Rakov V; Lang E;
    Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding patterns during continuous estradiol with different sequential progestogens therapy.
    Di Carlo C; Sammartino A; Di Spiezio Sardo A; Tommaselli GA; Guida M; Mandato VD; D'Elia A; Nappi C
    Menopause; 2005; 12(5):520-5. PubMed ID: 16145305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding.
    Warren MP; Biller BM; Shangold MM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):42-8. PubMed ID: 9914576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.
    Simon JA; Robinson DE; Andrews MC; Hildebrand JR; Rocci ML; Blake RE; Hodgen GD
    Fertil Steril; 1993 Jul; 60(1):26-33. PubMed ID: 8513955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome.
    Livadas S; Boutzios G; Economou F; Alexandraki K; Xyrafis X; Christou M; Zerva A; Karachalios A; Tantalaki E; Diamanti-Kandarakis E
    Fertil Steril; 2010 Jun; 94(1):242-6. PubMed ID: 19409554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
    Sun A; Lin S; Wei Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronized progesterone: clinical indications and comparison with current treatments.
    Fitzpatrick LA; Good A
    Fertil Steril; 1999 Sep; 72(3):389-97. PubMed ID: 10519605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.